News
William Blair Initiates Coverage On Neurogene with Outperform Rating
21 Mar 24
News, Initiation, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Neurogene, Raises Price Target to $55
19 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Neurogene, Maintains $45 Price Target
5 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical Trial
4 Mar 24
News
Press releases
Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates
18 Mar 24
Press Releases
Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical Trial
4 Mar 24
Press Releases
Neurogene to Participate in Upcoming Investor Conferences
29 Feb 24
Press Releases